Stem cells in prostate cancer: Treating the root of the problem

Endocrine-Related Cancer

Volumn 17, Issue 4, 2010, Pages

  Taylor, Renea A ^a   Toivanen, Roxanne ^a   Risbridger, Gail P ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER THERAPY; CELL DIFFERENTIATION; CELL LINEAGE; HUMAN; NONHUMAN; PROSTATE CANCER; PROSTATE EPITHELIUM; REVIEW; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; DISEASE PROGRESSION; HUMANS; MALE; NEOPLASMS, HORMONE-DEPENDENT; NEOPLASTIC STEM CELLS; PROSTATIC NEOPLASMS;

EID: 78649865054     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-10-0145     Document Type: Review

References (87)

1. Abrahamsson PA 1999 Neuroendocrine cells in tumour growth of the prostate. Endocrine-Related Cancer 6 503-519. (doi:10.1677/erc.0.0060503)
2. Ao M, Franco OE, Park D, Raman D, Williams K & Hayward SW 2007 Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Research 67 4244-4253. (doi:10.1158/0008-5472.CAN-06-3946)
3. Asselin-Labat ML, Shackleton M, Stingl J, Vaillant F, Forrest NC, Eaves CJ, Visvader JE & Lindeman GJ 2006 Steroid hormone receptor status of mouse mammary stem cells. Journal of the National Cancer Institute 98 1011-1014. (doi:10.1093/jnci/djj267)
4. Asselin-Labat ML, Vaillant F, Sheridan JM, Pal B, Wu D, Simpson ER, Yasuda H, Smyth GK, Martin TJ, Lindeman GJ et al. 2010 Control of mammary stem cell function by steroid hormone signalling. Nature 465 798-802. (doi:10.1038/nature09027)
5. Birnie R, Bryce SD, Roome C, Dussupt V, Droop A, Lang SH, Berry PA, Hyde CF, Lewis JL, Stower MJ et al. 2008 Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions. Genome Biology 9 R83. (doi:10.1186/gb-2008-9- 5-r83)
6. Bonkhoff H 1996 Role of the basal cells in premalignant changes of the human prostate: a stem cell concept for the development of prostate cancer. European Urology 30 201-205.
7. Bonkhoff H & Remberger K 1993 Widespread distribution of nuclear androgen receptors in the basal cell layer of the normal and hyperplastic human prostate. Virchows Archiv. A, Pathological Anatomy and Histopathology 422 35-38. (doi:10.1007/BF01605130)
8. Bonkhoff H, Stein U & Remberger K 1994 The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate 24 114-118. (doi:10.1002/pros.2990240303)
9. Bonnet D & Dick JE 1997 Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine 3 730-737. (doi:10.1038/nm0797-730)
10. Bostwick D & Dundore P 1997 Normal anatomy and histology. In Biopsy Pathology of the Prostate, 1st edn, pp 1-26. Eds AM Neville, F Walker, CR Taylor & LS Gottlieb. London, UK: Chapman & Hall.
11. Burger PE, Xiong X, Coetzee S, Salm SN, Moscatelli D, Goto K & Wilson EL 2005 Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. PNAS 102 7180-7185. (doi:10.1073/pnas.0502761102)
12. Campbell LL & Polyak K 2007 Breast tumor heterogeneity: cancer stem cells or clonal evolution? Cell Cycle 6 2332-2338.
13. Chung LW & Cunha GR 1983 Stromal-epithelial interactions: II. Regulation of prostatic growth by embryonic urogenital sinus mesenchyme. Prostate 4 503-511. (doi:10.1002/pros.2990040509)
14. Coffey DS 1992 The molecular biology, endocrinology, and physiology of the prostate and seminal vesicles. In Campbell's Urology, 6th edn, pp 221-301. Eds PC Walsh, AB Retik, TA Stamey & ED Vaughan. Philadelphia PA, USA: WB Saunders.
15. Collins AT, Habib FK, Maitland NJ & Neal DE 2001 Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)- integrin expression. Journal of Cell Science 114 3865-3872.
16. Collins AT, Berry PA, Hyde C, Stower MJ & Maitland NJ 2005 Prospective identification of tumorigenic prostate cancer stem cells. Cancer Research 65 10946-10951. (doi:10.1158/0008-5472.CAN-05-2018)
17. Cunha AR 1994 Role of mesenchymal-epthelial interactions in normal and abnormal development of male urogenital glands. In Ultrastructure of Male Urogenital Glands: Prostate, Seminal Vesicles, Urethral, and Bulbourethral Glands, Eds A Riva, F Testa Riva & PM Motta. Boston, MA, USA: Kluwer Academic Publishers.
18. Cunha GR & Donjacour AA 1989 Mesenchymal-epithelial interactions in the growth and development of the prostate. Cancer Treatment and Research 46 159-175.
19. De Marzo AM, Meeker AK, Epstein JI & Coffey DS 1998 Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells. American Journal of Pathology 153 911-919.
20. DeKlerk DP & Coffey DS 1978 Quantitative determination of prostatic epithelial and stromal hyperplasia by a new technique. Biomorphometrics. Investigative Urology 16 240-245.
21. Dick JE 2009 Looking ahead in cancer stem cell research. Nature Biotechnology 27 44-46. (doi:10.1038/nbt0109-44)
22. Donjacour A & Cunha G 1993 Assessment of prostatic protein secretion in tissue recombinants made of urogenital sinus mesenchyme and urothelium from normal or androgen-insensitive mice. Endocrinology 132 2342-2350. (doi:10.1210/en.132.6.2342)
23. El-Alfy M, Pelletier G, Hermo LS & Labrie F 2000 Unique features of the basal cells of human prostate epithelium. Microscopy Research and Technique 51 436-446. (doi:10.1002/1097-0029(20001201)51:5〈436::AID-JEMT6〉3.0. CO;2-T)
24. Ellem SJ & Risbridger GP 2007 Treating prostate cancer: a rationale for targeting local oestrogens. Nature Reviews. Cancer 7 621-627. (doi:10.1038/nrc2174)
25. Ellwood-Yen K, Graeber TG, Wongvipat J, Iruela-Arispe ML, Zhang J, Matusik R, Thomas GV & Sawyers CL 2003 Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 4 223-238. (doi:10.1016/S1535-6108(03)00197-1)
26. Foster CS, Dodson A, Karavana V, Smith PH & Ke Y 2002 Prostatic stem cells. Journal of Pathology 197 551-565. (doi:10.1002/path.1194)
27. Goldstein AS, Lawson DA, Cheng D, Sun W, Garraway IP & Witte ON 2008 Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. PNAS 105 20882-20887. (doi:10.1073/pnas.0811411106)
28. Grisanzio C & Signoretti S 2008 p63 in prostate biology and pathology. Journal of Cellular Biochemistry 103 1354-1368. (doi:10.1002/jcb. 21555)
29. Hanahan D & Weinberg RA 2000 The hallmarks of cancer. Cell 100 57-70. (doi:10.1016/S0092-8674(00)81683-9)
30. Hayward SW, Rosen MA & Cunha GR 1997 Stromal-epithelial interactions in the normal and neoplastic prostate. British Journal of Urology 79 (Suppl 2) 18-26.
31. Heer R, Robson CN, Shenton BK & Leung HY 2007 The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population. Journal of Cellular Physiology 212 572-578. (doi:10.1002/jcp.21154)
32. Henshall SM, Quinn DI, Lee CS, Head DR, Golovsky D, Brenner PC, Delprado W, Stricker PD, Grygiel JJ & Sutherland RL 2001 Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer. Cancer Research 61 423-427.
33. Hudson DL 2004 Epithelial stem cells in human prostate growth and disease. Prostate Cancer and Prostatic Diseases 7 188-194. (doi:10.1038/sj.pcan. 4500745)
34. Humphrey PA 2007 Diagnosis of adenocarcinoma in prostate needle biopsy tissue. Journal of Clinical Pathology 60 35-42. (doi:10.1136/jcp.2005.036442)
35. Isaacs JT & Coffey DS 1989 Etiology and disease process of benign prostatic hyperplasia. Prostate. Supplement 2 33-50. (doi:10.1002/pros. 2990150506)
36. Iwata T, Schultz D, Hicks J, Hubbard GK, Mutton LN, Lotan TL, Bethel C, Lotz MT, Yegnasubramanian S, Nelson WG et al. 2010 MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells. PLoS ONE 5 e9427. (doi:10.1371/journal.pone.0009427)
37. Joesting MS, Perrin S, Elenbaas B, Fawell SE, Rubin JS, Franco OE, Hayward SW, Cunha GR & Marker PC 2005 Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer. Cancer Research 65 10423-10430. (doi:10.1158/0008-5472.CAN-05-0824)
38. Kelly PN, Dakic A, Adams JM, Nutt SL & Strasser A 2007 Tumor growth need not be driven by rare cancer stem cells. Science 317 337. (doi:10.1126/science.1142596)
39. Kurita T, Medina RT, Mills AA & Cunha GR 2004 Role of p63 and basal cells in the prostate. Development 131 4955-4964. (doi:10.1242/dev.01384)
40. Kyprianou N & Isaacs JT 1988 Identification of a cellular receptor for transforming growth factor-beta in rat ventral prostate and its negative regulation by androgens. Endocrinology 123 2124-2131. (doi:10.1210/endo-123-4- 2124)
41. Lawson DA, Xin L, Lukacs RU, Cheng D & Witte ON 2007 Isolation and functional characterization of murine prostate stem cells. PNAS 104 181-186. (doi:10.1073/pnas.0609684104)
42. Lawson DA, Zong Y, Memarzadeh S, Xin L, Huang J & Witte ON 2010 Basal epithelial stem cells are efficient targets for prostate cancer initiation. PNAS 107 2610-2615. (doi:10.1073/pnas.0913873107)
43. Leav I, Lau KM, Adams JY, McNeal JE, Taplin ME, Wang J, Singh H & Ho SM 2001 Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. American Journal of Pathology 159 79-92.
44. van Leenders GJ & Schalken JA 2001 Stem cell differentiation within the human prostate epithelium: implications for prostate carcinogenesis. BJU International 88 (Suppl 2) 35-42 (discussion 49-50). (doi:10.1046/j.1464-410X. 2001.00117.x)
45. Leong KG, Wang BE, Johnson L & Gao WQ 2008 Generation of a prostate from a single adult stem cell. Nature 456 804-808. (doi:10.1038/nature07427)
46. Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, Asselin-Labat ML, Gyorki DE, Ward T, Partanen A et al. 2009 Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nature Medicine 15 907-913. (doi:10.1038/nm.2000)
47. Liu AY, True LD, LaTray L, Nelson PS, Ellis WJ, Vessella RL, Lange PH, Hood L & van den Engh G 1997 Cell-cell interaction in prostate gene regulation and cytodifferentiation. PNAS 94 10705-10710. (doi:10.1073/pnas.94. 20.10705)
48. Locke JA, Guns ES, Lubik AA, Adomat HH, Hendy SC, Wood CA, Ettinger SL, Gleave ME & Nelson CC 2008 Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer. Cancer Research 68 6407-6415. (doi:10.1158/0008-5472.CAN-07-5997)
49. Lukacs RU, Goldstein AS, Lawson DA, Cheng D & Witte ON 2010 Isolation, cultivation and characterization of adult murine prostate stem cells. Nature Protocols 5 702-713. (doi:10.1038/nprot.2010.11)
50. Ma X, Ziel-van der Made AC, Autar B, van der Korput HA, Vermeij M, van Duijn P, Cleutjens KB, de Krijger R, Krimpenfort P, Berns A et al. 2005 Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis. Cancer Research 65 5730-5739. (doi:10.1158/0008-5472.CAN-04-4519)
51. McNeal JE 1981 Normal and pathologic anatomy of prostate. Urology 17 11-16.
52. McNeal JE 1988 Normal histology of the prostate. American Journal of Surgical Pathology 12 619-633. (doi:10.1097/00000478-198808000-00003)
53. McPherson SJ, Hussain S, Balanathan P, Hedwards S, Niranjan B, Grant M, Chandrasiri UP, Toivanen R, Wang Y, Taylor RA et al. 2010 Estrogen receptor beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen-independent and TNF-A mediated. PNAS 107 3123-3128. (doi:10.1073/pnas.0905524107)
54. Montpetit M, Abrahams P, Clark AF & Tenniswood M 1988 Androgen-independent epithelial cells of the rat ventral prostate. Prostate 12 13-28. (doi:10.1002/pros.2990120104)
55. Mulholland DJ, Xin L, Morim A, Lawson D, Witte O & Wu H 2009 Lin-Sca-1+CD49f high stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model. Cancer Research 69 8555-8562. (doi:10.1158/0008-5472.CAN-08-4673)
56. O'Brien CA, Pollett A, Gallinger S & Dick JE 2007 A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445 106-110. (doi:10.1038/nature05372)
57. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD & Cunha GR 1999 Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Research 59 5002-5011.
58. Penson D & Chan J 2007 Urological diseases in America project: Prostate cancer. Journal of Urology 177 2020-2029. (doi:10.1016/j.juro.2007.01. 121)
59. Potten CS & Loeffler M 1990 Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 110 1001-1020.
60. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM & Morrison SJ 2008 Efficient tumour formation by single human melanoma cells. Nature 456 593-598. (doi:10.1038/nature07567)
61. Reya T, Morrison SJ, Clarke MF & Weissman IL 2001 Stem cells, cancer, and cancer stem cells. Nature 414 105-111. (doi:10.1038/35102167)
62. Ricciardelli C, Choong CS, Buchanan G, Vivekanandan S, Neufing P, Stahl J, Marshall VR, Horsfall DJ & Tilley WD 2005 Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify nonorgan confined disease. Prostate 63 19-28. (doi:10.1002/pros.20154)
63. Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ & Collins AT 2004 CD133, a novel marker for human prostatic epithelial stem cells. Journal of Cell Science 117 3539-3545. (doi:10.1242/jcs.01222)
64. Risbridger GP, Davis ID, Birrell SN & Tilley W 2010 Breast and prostate cancer: more similar than different. Nature Reviews. Cancer 10 205-212. (doi:10.1038/nrc2795)
65. Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, Gasser M, Zhan Q, Jordan S, Duncan LM, Weishaupt C et al. 2008 Identification of cells initiating human melanomas. Nature 451 345-349. (doi:10.1038/nature06489)
66. Scher HI, Buchanan G, Gerald W, Butler LM & Tilley WD 2004 Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer. Endocrine-Related Cancer 11 459-476. (doi:10.1677/erc.1.00525)
67. Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ & Visvader JE 2006 Generation of a functionalmammary gland from a single stem cell. Nature 439 84-88. (doi:10.1038/nature04372)
68. Shackleton M, Quintana E, Fearon ER & Morrison SJ 2009 Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 138 822-829. (doi:10.1016/j.cell.2009.08.017)
69. Shepherd CJ, Rizzo S, Ledaki I, Davies M, Brewer D, Attard G, de Bono J & Hudson DL 2008 Expression profiling of CD133+ and CD133- epithelial cells from human prostate. Prostate 68 1007-1024. (doi:10.1002/pros.20765)
70. Signoretti S & Loda M 2007 Prostate stem cells: from development to cancer. Seminars in Cancer Biology 17 219-224. (doi:10.1016/j.semcancer.2006.04. 004)
71. Signoretti S, Waltregny D, Dilks J, Isaac B, Lin D, Garraway L, Yang A, Montironi R, McKeon F & Loda M 2000 p63 is a prostate basal cell marker and is required for prostate development. American Journal of Pathology 157 1769-1775.
72. Takeda H, Suematsu N & Mizuno T 1990 Transcription of prostatic steroid binding protein (PSBP) gene is induced by epithelial-mesenchymal interaction. Development 110 273-281. (Pubitemid 20287234)
73. Taylor RA & Risbridger GP 2008 Prostatic tumor stroma: a key player in cancer progression. Current Cancer Drug Targets 8 490-497. (doi:10.2174/156800908785699351)
74. Taylor RA, Wang H, Wilkinson SE, Richards MG, Britt KL, Vaillant F, Lindeman GJ, Visvader JE, Cunha GR, St John J et al. 2009 Lineage enforcement by inductive mesenchyme on adult epithelial stem cells across developmental germ layers. Stem Cells 27 3032-3042. (doi:10.1002/stem.244)
75. Tsujimura A, Fujita K, Komori K, Takao T, Miyagawa Y, Takada S, Matsumiya K, Nonomur N & Okuyama A 2007 Prostatic stem cell marker identified by cDNA microarray in mouse. Journal of Urology 178 686-691. (doi:10.1016/j.juro.2007. 03.092)
76. Uzgare AR, Xu Y & Isaacs JT 2004 In vitro culturing and characteristics of transit amplifying epithelial cells from human prostate tissue. Journal of Cellular Biochemistry 91 196-205. (doi:10.1002/jcb.10764)
77. Vander Griend DJ, Karthaus WL, Dalrymple S, Meeker A, DeMarzo AM & Isaacs JT 2008 The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Research 68 9703-9711. (doi:10.1158/0008-5472.CAN-08-3084)
78. Verhagen AP, Aalders TW, Ramaekers FC, Debruyne FM & Schalken JA 1988 Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration. Prostate 13 25-38. (doi:10.1002/pros.2990130104)
79. Visvader JE 2009 Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes and Development 23 2563-2577. (doi:10.1101/gad. 1849509)
80. Wang Y, Hayward S, Cao M, Thayer K & Cunha G 2001 Cell differentiation lineage in the prostate. Differentiation 68 270-279. (doi:10.1046/j.1432-0436.2001.680414.x)
81. Wang S, Garcia AJ, Wu M, Lawson DA, Witte ON & Wu H 2006 Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation. PNAS 103 1480-1485. (doi:10.1073/pnas. 0510652103)
82. Wang X, Kruithof-de Julio M, Economides KD, Walker D, Yu H, Halili MV, Hu YP, Price SM, Abate-Shen C & Shen MM 2009 A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 461 495-500. (doi:10.1038/nature08361)
83. Watt FM & Hogan BL 2000 Out of Eden: stem cells and their niches. Science 287 1427-1430. (doi:10.1126/science.287.5457.1427)
84. Wicha MS, Liu S & Dontu G 2006 Cancer stem cells: an old idea - a paradigm shift. Cancer Research 66 1883-1890 (discussion 1895-1886). (doi:10.1158/0008-5472.CAN-05-3153)
85. Wikstrom P, Marusic J, Stattin P & Bergh A 2009 Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients. Prostate 69 799-809. (doi:10.1002/pros.20927)
86. Xin L, Lawson DA & Witte ON 2005 The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. PNAS 102 6942-6947. (doi:10.1073/pnas.0502320102)
87. Yao M, Taylor RA, Richards MG, Sved P, Wong J, Eisinger D, Xie C, Salomon R, Risbridger GP & Dong Q 2010 Prostate-regenerating capacity of cultured human adult prostate epithelial cells. Cells, Tissues, Organs 191 203-212. (doi:10.1159/000240244)